Sector: MedicalCel-Sci Corporation (AMEX: CVM)
Headlines
- CEL-SCI Announces Start of First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine
Nov 18, 2009 09:45 AM | CVM
- Is Amendment of Previously Filed Paperwork a Sign That CEL-SCI is Expecting Something Big?
Nov 12, 2009 07:30 AM | CVM
- CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response
Nov 09, 2009 09:40 AM | CVM
- D.C. Vaccine Conference Attracts Government Policy Makers and Biotech Innovators
Nov 09, 2009 08:26 AM | CVM
- CEL-SCI's H1N1 Clinical Study News Seen as Credibility Booster
Nov 06, 2009 02:39 PM | CVM, OMPI, ZGEN
- CEL-SCI's L.E.A.P.S.(TM) H1N1 Flu Development Seen as Credibility Booster
Nov 06, 2009 12:34 PM | CVM
- CEL-SCI to Conduct First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine
Nov 06, 2009 09:45 AM | CVM
- CEL-SCI Corporation Strengthens Balance Sheet Through Receipt of $10 Million From Warrant Exercises
Oct 26, 2009 09:55 AM | CVM
- Completion of Cel-Sci's New Facility Signals That Long Awaited Phase III Trial is Imminent
Oct 26, 2009 07:15 AM | CVM
- CEL-SCI's L.E.A.P.S.(TM) Inventor Excited by H1N1 Treatment's Progress
Oct 20, 2009 09:54 AM | CVM
- PicksThatMove.com Announces Investment Opinion Huntington Bancshares Inc., Goldcorp, CEL-SCI Corporation, Viking Systems, Inc., Yamana Gold Inc.
Nov 03, 2009 06:55 PM | AUY, CVM, GG, HBAN
- Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter
Oct 20, 2009 04:10 PM | AGEN, CVM, DNDN, GNBT, ONTY
- Mentor Capital Cancer Immunotherapy Index Posts Second 20% Plus Monthly Gain Lead By ImmunoCellular Therapeutics
Sep 16, 2009 10:18 AM | AGEN, CVM, DNDN, GNBT, ONTY
- New Cancer Immunotherapy Index Posts 23% Gains Lead By Mentor Capital, Inc. And Oncothyreon
Aug 28, 2009 02:11 PM | AGEN, CVM, DNDN, GNBT, ONTY
- CEL-SCI Signs Definitive Agreement to Raise $4.4 Million in Registered Direct Offering
Aug 20, 2009 09:53 AM | CVM
- CEL-SCI Expands H1N1 Flu Virus Work
Aug 18, 2009 10:10 AM | CVM
- CEL-SCI Corporation Reports Third Quarter 2009 Financial Results
Aug 14, 2009 05:51 PM | CVM
- CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
Jul 10, 2009 08:30 AM | CVM
- CEL-SCI Corporation Releases Letter to Shareholders
Jul 07, 2009 09:45 AM | CVM
- CEL-SCI Completes $5.85 Million Registered Direct Offering
Jun 30, 2009 12:56 PM | CVM
- Form 4 CEL SCI CORP For: Nov 18 Filed by: DE CLARA MAXIMILIAN (10K)
Nov 20, 2009 05:48 PM
- Form 3 CIPRIANO JOHN For: Oct 01 (10K)
Oct 07, 2009 07:02 PM
- Form 4 TALOR EYAL For: Jul 06 (10K)
Sep 25, 2009 06:21 PM
- Form 4 PRICHEP PATRICIA B For: Jul 06 (10K)
Sep 25, 2009 06:17 PM
- Form 4 YOUNG PETER R For: Jul 06 (10K)
Jul 31, 2009 07:12 PM
- Form 4 KINSOLVING C RICHARD For: Jul 06 (10K)
Jul 31, 2009 07:06 PM
- Form 4 ESTERHAZY ALEXANDER G For: Jul 06 (10K)
Jul 31, 2009 06:59 PM
- Form 4 TALOR EYAL For: Jul 21 (10K)
Jul 31, 2009 06:58 PM
- Form 4 PRICHEP PATRICIA B For: Jul 21 (10K)
Jul 31, 2009 06:50 PM
- Form 4 KERSTEN GEERT R For: Jul 06 (10K)
Jul 31, 2009 06:39 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CVM
|
Compare to S&P
|
| YTD |
363.16 %
|
282.58 %
|
| 4 Weeks |
-17.50 %
|
-17.94 %
|
| 12 Weeks |
194.84 %
|
176.68 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -150.00 %
|
|
EPS Growth in Last Year: -350.00 %
|
|
Sales Growth in Last Quarter: 50.00 %
|
|
Sales Growth in Last Quarter: 650.00 %
|
|
